Agilent Technologies to acquire Biocare Medical in $950m deal
Agilent Technologies has agreed to acquire pathology solutions provider Biocare Medical in a cash transaction worth $950m. The acquisition will give …
Post
-
-
Philips advances cardiac MR with FDA clearance for SmartHeart AI
The US Food and Drug Administration (FDA) has cleared Philips’ SmartHeart AI, setting clinicians up with a tool to streamline …
-
Vinay Prasad to leave the FDA again
Vinay Prasad is once again set to depart from his role at the US Food and Drug Administration (FDA), after …
-
Francis Medical concludes first commercial procedures with Vanquish system
Francis Medical has concluded the first commercial procedures using its Vanquish water vapour ablation system for prostate tissue ablation in …
-
LifeVac receives FDA De Novo classification for anti-choking device
LifeVac has received De Novo classification from the US Food and Drug Administration (FDA) for its suction anti-choking device under …
-
Women first: the Gulf’s new healthcare blueprint
Nabta Health, a Dubai-based women's health company, is up for a prestigious MedTech award, but its founder Sophie Smith has …
-
Roche survey highlights demand for predictive tools for diabetes management
A new global survey of diabetes patients conducted by Roche has revealed a desire for predictive tools to help them …
-
Science Corporation raises $230m to support retinal BCI implant commercialisation
Science Corporation has raised $230m to advance commercial activities for its Prima brain-computer interface (BCI) retinal implant for vision restoration. The …
-
Neuspera reports positive data in urinary urge incontinence device trial
Neuspera Medical has reported encouraging 12-month pivotal trial results for its integrated sacral neuromodulation system (iSNM), Neuspera SNM, in patients …
-
Cognita secures FDA breakthrough device designation for CXR
Cognita has received the US Food and Drug Administration (FDA) breakthrough device designation for the Chest X-Ray (CXR) model across …
-
Cognito Therapeutics raises $105m for Alzheimer’s therapeutic advancement
Cognito Therapeutics has raised $105m to advance the clinical development and commercial preparedness for its Alzheimer’s disease therapeutic. The Massachusetts-based company’s …
-
Daiichi and GAIA join forces to commercialise digital cardiovascular therapy
Daiichi Sankyo’s European faction and health technology company GAIA have banded together to commercialise a digital therapeutic designed to support …
-
Bayer secures expanded FDA clearances for MRI contrast agent injector
The US Food and Drug Administration (FDA) has granted expanded clearance to Bayer’s Medrad MRXperion, broadening the magnetic resonance (MR) injection …
-
Airiver Medical receives FDA breakthrough device status for DCB
Airiver Medical has secured the US Food and Drug Administration (FDA) breakthrough device designation for its pulmonary drug-coated balloon (DCB) …
-
Philips launches Rembra CT system for acute imaging
Philips has unveiled its next-generation radiology computed tomography (CT) system, Rembra, to address the challenges faced by acute and high-demand …
